Fig. 2From: Endocrine therapy initiation, discontinuation and adherence and breast imaging among 21-gene recurrence score assay-eligible women under age 65Kaplan-Meier curves for continuation of endocrine therapy among (a) all test-eligible women, (b) by tested status, and (c) by RS categoryBack to article page